TNSN08497A1 - Composition nasale et buccale pour lutter contre le ronflement - Google Patents

Composition nasale et buccale pour lutter contre le ronflement

Info

Publication number
TNSN08497A1
TNSN08497A1 TNP2008000497A TNSN08497A TNSN08497A1 TN SN08497 A1 TNSN08497 A1 TN SN08497A1 TN P2008000497 A TNP2008000497 A TN P2008000497A TN SN08497 A TNSN08497 A TN SN08497A TN SN08497 A1 TNSN08497 A1 TN SN08497A1
Authority
TN
Tunisia
Prior art keywords
nasal
fight
snow
oral composition
composition
Prior art date
Application number
TNP2008000497A
Other languages
English (en)
Inventor
Serge Sonie
Jean-Christophe Anton
Denis Marin
Original Assignee
Omega Pharma Capital Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0651998A external-priority patent/FR2901705A1/fr
Application filed by Omega Pharma Capital Nv filed Critical Omega Pharma Capital Nv
Publication of TNSN08497A1 publication Critical patent/TNSN08497A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne l'utilisation d'une composition nasale et d'une composition buccale pour la préparation d'une composition combinée pour une utilisation simultanée, séquentielle ou séparée pour le traitement ou la prévention des ronflements chez un sujet plus particulièrement chez un gros ronfleur.
TNP2008000497A 2006-06-01 2008-11-28 Composition nasale et buccale pour lutter contre le ronflement TNSN08497A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0651998A FR2901705A1 (fr) 2006-06-01 2006-06-01 Composition pour lutter contre le ronflement se presentant sous la forme d'un spray nasal
FR0701176A FR2901706A1 (fr) 2006-06-01 2007-02-19 Compositions nasale et buccale pour lutter contre le ronflement
PCT/FR2007/051341 WO2007138224A1 (fr) 2006-06-01 2007-05-29 Compositions nasale et buccale pour lutter contre le ronflement

Publications (1)

Publication Number Publication Date
TNSN08497A1 true TNSN08497A1 (fr) 2010-04-14

Family

ID=38647216

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000497A TNSN08497A1 (fr) 2006-06-01 2008-11-28 Composition nasale et buccale pour lutter contre le ronflement

Country Status (13)

Country Link
EP (1) EP2026835B1 (fr)
JP (1) JP2009538888A (fr)
AU (1) AU2007266902A1 (fr)
BR (1) BRPI0711253A2 (fr)
CA (1) CA2653916A1 (fr)
EA (1) EA200802262A1 (fr)
ES (1) ES2434113T3 (fr)
FR (1) FR2901706A1 (fr)
MA (1) MA30489B1 (fr)
NO (1) NO20085137L (fr)
RU (1) RU2008146888A (fr)
TN (1) TNSN08497A1 (fr)
WO (1) WO2007138224A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008189568A (ja) * 2007-02-02 2008-08-21 Sceti Kk いびき症の予防または治療のための口腔用液状剤用またはフィルム状剤用組成物、及びこれを含む口腔用製品
FR2940761B1 (fr) 2009-01-07 2012-12-28 Polymerexpert Sa Composition anti-ronflement contenant un polymere thermogelifiant
CN105982669A (zh) * 2015-03-02 2016-10-05 罗远明 膈肌肌电判断下气道阻力

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060057227A1 (en) * 2002-02-15 2006-03-16 Fisher Jeffrey J Throat spray
RU2005101331A (ru) * 2002-06-20 2006-01-20 Новартис Консьюмер Хелс С.А. (Ch) Назальная композиция, включающая мукополисахарид и пропиленгликоль
AU2003263162B2 (en) * 2002-10-24 2009-05-07 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
FR2876585B1 (fr) * 2004-10-20 2008-09-12 Persee Medica Composition pour lutter contre le ronflement

Also Published As

Publication number Publication date
AU2007266902A1 (en) 2007-12-06
RU2008146888A (ru) 2010-07-20
WO2007138224A1 (fr) 2007-12-06
EP2026835B1 (fr) 2013-08-21
BRPI0711253A2 (pt) 2011-08-30
NO20085137L (no) 2009-02-27
EP2026835A1 (fr) 2009-02-25
FR2901706A1 (fr) 2007-12-07
EA200802262A1 (ru) 2009-08-28
ES2434113T3 (es) 2013-12-13
MA30489B1 (fr) 2009-06-01
JP2009538888A (ja) 2009-11-12
CA2653916A1 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
MA32226B1 (fr) Compositions et leurs procedes de preparation et d'utilisation
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
GB2414933B (en) Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
MA32397B1 (fr) Agonistes mixtes basés sur gip destinés au traitement de troubles métaboliques et de l'obésité
EP1799269A4 (fr) Oligoribonucléotides et procédés d'utilisation associés pour le traitement de l'alopécie, des insuffisances rénales aiguës et d'autres maladies
MA30914B1 (fr) Dihydropyrazolones substituees utilisees dans le traitement de maladies cardiovasculaires et hematologiques.
EP2101757A4 (fr) Composé pour le traitement ou la prévention de maladies en relation avec la prostate et compositions pharmaceutiques de système d'administration par le colon contenant ce composé
MA28437B1 (fr) Composes et leurs procedes d'utilisation
MA31606B1 (fr) Anticorps anti-cd 79b immunoconjugues et procedes d'utilisation
MA31605B1 (fr) Anticorps anti-cd79b humanisés, immunoconjugués, et procédés d'utilisation
MA32070B1 (fr) Dérivés hétérocycliques réunis par fusion et procédés d'utilisation associés
MY153198A (en) Inhibitors of protein aggregation
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
WO2007143674A3 (fr) Procédés pour des posologies buccales, linguales ou sublinguales d'epinéphrine pour le traitement d'urgences allergiques
EP1804761A4 (fr) Compositions et methodes pour traitement des dyschromies cutanees
EP1865967A4 (fr) Composes, compositions et methodes de traitement d'infections virales et autres troubles medicaux
WO2006007136A3 (fr) Formulations dentaires anti-microbiennes destinees a la prevention et au traitement de maladies mucosales buccales
IL164370A0 (en) Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
PL1633376T3 (pl) Środki do profilaktyki i leczenia objawów przeziębienia i grypopodobnych zawierające chelatowany cynk
TW200738669A (en) Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide
EP2101799A4 (fr) Utilisation d'agents anaboliques, d'agents anticataboliques, d'agents antioxydants, et de substances analgésiques pour la protection, traitement et la réparation des tissus conjonctifs chez l'homme et l'animal
EP1786428A4 (fr) Compositions d'inhibiteur pde5 et methodes de traitement des troubles cardiaques
EP2001488A4 (fr) Prevention et traitement des cancers et d'autres maladies
FR2930552B1 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog